| Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression I Dogan, E Aydin, N Khanmammadov, N Paksoy, P Saip, A Aydiner Scientific Reports 13 (1), 8779, 2023 | 6 | 2023 |
| Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study N Paksoy, N Khanmammadov, İ Doğan, F Ferhatoğlu, MA Ahmed, ... Medicine 102 (5), e32866, 2023 | 4 | 2023 |
| Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study N Paksoy, N Khanmammadov, İ Doğan, F Ferhatoğlu, A Yildiz, N Ak, ... Medicine 101 (45), e31726, 2022 | 3 | 2022 |
| Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience İ DOĞAN, N Khanmammadov, M Ahmed, A Yildiz, P Saip, A Aydiner, ... Clinical Cancer Investigation Journal, 2022 | 2 | 2022 |
| Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience D Tastekin, N Paksoy, I Dogan, F Ferhatoglu, N Khanmammadov, ... Journal of cancer research and therapeutics 19 (2), 253-258, 2023 | 1 | 2023 |
| Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group M Gürbüz, S Kiliçkap, A Bilici, N Karadurmuş, A Sezer, MAN Şendur, ... Medicine 101 (50), e32368, 2022 | 1 | 2022 |
| Assessment of serum endocan levels in patients with beta-thalassemia minor N Khanmammadov, M Zorlu, OF Ozer, C Karatoprak, M Kıskaç, M Çakırca Revista da Associação Médica Brasileira 68, 147-151, 2022 | 1 | 2022 |
| Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib İ DOĞAN, N Khanmammadov, M Ahmed, A Yildiz, P Saip, A Aydiner, ... Clinical Cancer Investigation Journal, 2022 | 1 | 2022 |
| Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib İ Dogan, N Khanmammadov, N Paksoy, F Ferhatoglu, E Aydın, ... TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY 37, 2022 | 1 | 2022 |
| Clinical factors predicting objective response to bevacizumab-based chemotherapies in advanced and recurrent epithelial ovarian cancer. N Khanmammadov, I Dogan, NS Okay, B Khishigsuren, A Azizy, P Saip, ... Minerva Obstetrics and Gynecology, 2024 | | 2024 |
| Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study F Ferhatoglu, N Paksoy, N Khanmammadov, A Yildiz, MA Ahmed, ... Medicine 103 (8), e37213, 2024 | | 2024 |
| Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey S Karabulut, CU Afsar, N Khanmammadov, L Karahan, N Paksoy, I Dogan, ... Journal of Cancer Research and Therapeutics, 10.4103, 2024 | | 2024 |
| Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer N KHANMAMMADOV, İ DOĞAN, NS OKAY, A YILDIZ, B KHISHIGSUREN, ... TURKISH JOURNAL OF ONCOLOGY 39 (2), 2024 | | 2024 |
| Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients I Dogan, E Aydin, N Khanmammadov, N Paksoy, F Ferhatoğlu, N Ak, ... Journal of Cancer Research and Clinical Oncology 149 (16), 14833-14841, 2023 | | 2023 |
| Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center N Khanmammadov, N Paksoy, I Doğan, F Ferhatoğlu, P Saip, ... Medicine 102 (39), e35383, 2023 | | 2023 |
| Outcomes of the patients with metastatic male breast cancer I Dogan, N Khanmammadov, S Ozkurt, A Aydiner, P Saip Journal of Cancer Research and Therapeutics, 2023 | | 2023 |
| Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors I Dogan, N Khanmammadov, A Yıldız, MA Ahmed, S Vatansever, P Saip, ... Journal of Cancer Research and Therapeutics, 2023 | | 2023 |
| Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer. N Khanmammadov, I Dogan, P Saip, A Aydiner Journal of Clinical Oncology 41 (16_suppl), e17537-e17537, 2023 | | 2023 |
| Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors I Dogan, N Khanmammadov, N Paksoy, S Vatansever, P Saip, A Aydıner Eurasian Journal of Pulmonology 25 (1), 27, 2023 | | 2023 |
| High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience N Paksoy, F Ferhatoglu, İ Dogan, N Khanmammadov, AI Celik, Z Gulbas, ... Medicine 101 (49), e32213, 2022 | | 2022 |
